Sernova Biotherapeutics (SVA.TO) Q2 2024 Earnings

14JunConfirmed
Q2 2023
Q4 2023
Q4 2023
Q2 2024
-0.03
-0.03
-0.02
-0.02

Details

Expected EPS
-0.0265204394373492
Actual EPS
-0.029835121428000003
Surprise EPS
-0
Surprise Percent
+12.5%

Description

Sernova Biotherapeutics (SVA.TO) has reported earnings of -0.029835121428000003 per share for Q2 2024.

0 Comments

Share your thoughts